Skip to content

TVTO™ X TVTS ™ for Treatment of Stress Urinary Incontinence

Comparative Study of TVTO™ X TVTS ™ for Treatment of Stress Urinary Incontinence

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01095159
Acronym
TVTOxTVTS
Enrollment
124
Registered
2010-03-30
Start date
2009-02-28
Completion date
2013-12-31
Last updated
2018-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stress Urinary Incontinence

Keywords

TVTO, TVTSecur, Mini sling, stress urinary incontinence

Brief summary

This is a prospective, comparative randomized controled trial. The general purposes of this study is to compare the efficacy and safety of TVTO™ and TVTSecur™ as surgical treatment for female urinary stress incontinence.

Interventions

DEVICETVT-O

Subjects of this group were submitted to surgical treatment of stress urinary incontinence with a transobturator sling TVT-O™ (Gynecare™, USA).

DEVICETVT-S

Subjects of this group were submitted to surgical treatment of stress urinary incontinence with a transobturator mini-sling; TVT-Secur™ (Gynecare™, USA).

Sponsors

Johnson & Johnson
CollaboratorINDUSTRY
Federal University of São Paulo
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* Clinical and urodynamic for stress urinary

Exclusion criteria

* Detrusor overactivity (urodynamic study) * Urodynamic changes suggesting reduced vesical capacity * Associated neurological diseases * Coagulopathies * Pregnancy * Foreign matter sensitiveness history * Acute urinary tract infection * Sequel from high ionizing radiation exposure * Use of drugs that may result in high surgical risk and/or significant postoperative complication * Anesthetic procedure contraindication * Vulvovaginitis: presence of vaginal secretion with infection clinically or lab supported

Design outcomes

Primary

MeasureTime frame
Compare the efficacy of employing the Gynecare TVT Secur™ with the traditional Gynecare TVT- O™ for treating female stress urinary incontinence.1 year

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026